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Pre-hospital ECG's were obtained in 2,011 (6.3%) of 31,939 NRMI-2 pa- 
tients who presented to the hospital within 12 hours of an AMI from 6/94 to 
7/95. Transfer or self-transport patients were excluded from this study. Me- 
dian t~me from AMI symptoms onset until hospital ardval was longer among 
those Vested with PH-ECG (2.8 hm vs 1.7 hrs, p < 0.001). However, once 
in the hospital, the PH-ECG treated group conferred a shorter median time 
to the initiation of reperfosion therapy with either thrombelysis (31 min vs 40 
rain, p < 0.001) or pdmory angioptasty (87 rain vs 117 rain, p < 0.001). 
The PH-ECG group was more I~ely to receive thrombelytic therapy (45% 
vs 38%, p < 0.001) and undergo pdmary angioplasty (18% vs 10%, p < 
0.001). Also, the PH-ECG group was more likely to obtain In-hospitat cardiac 
catheterization (54% vs 39%, p < 0.001), angioplasty (21% vs 15°/o, p < 
0,001) or bypass surgery (10% vs 6%, p < 0.001). Hospital mortality was 
7.9% in the PH-ECG group and 12.2% in those without PH-ECG (Io < 0.001 ). 
Alter adjusting for baseline differences utilizing multivariate analysis, this 
mortality difference remained statistically significant (p = 0.02). 
In NRMI-2, the pre-hespital ECG in diagnosing AMI leads to the wider, 
faster in-hospitat utilization of repertusion strategies, as well as the greater 
use of invesive procedures. These factom may help explain the mortality 
advantage seen in the PH-ECG treated group. 
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~ ABC-Leslon Risk Factor for the Type as 
Occurrence of Early and Late Clinical Events in 
Unstable Patients Following Trenslumlnal 
Coronary Angioplasty (PTCA) 
Jean-Paul R. Herrman, Rein Melkert, Rudiger Simon 1, Patrick W. Serruys, 
for the HELVETICA investigators. ~Medizinische UniversitatskUnik, Kiel, 
Germany and Thoraxcentre, Rotterdam, the Netherlands 
Introduction: This study was performed to investigate the relationship be- 
twesn ABC lesion type (AHA/ACC) and eady and tats adverse clinical events 
(4 and 210 days post-PTCA) such as death, myocardial infarction (MI), bail- 
outs, bypass surgery (CABG) and re-PTCA which hamper esults of PTCA. 
Methods: Study population compdsed 1140 patients, prospectively enmled 
in the HELVETICA study, in which hirudln (Hit) iv or iv + sc was compared to 
heparin (Hap) treatment in unstable patients undergoing PTCA for 163 type 
A, 447 type St, 416 type B2 and 114 type C lesions. In case of muitHesion 
dilatation, the most severe lesion type was considered. 
Results: The table presents eady and late ranked clinical ~vent rate in 
percent per lesion type. P-value is from chi-square test for categodcai ranked 
non-parametric variables. 
E~tdy events Late events 
Hir iv + sc Hir iv Hap Total Hit iv + sc Hit iv Hep Total 
N - 378 381 381 1140 378 381 381 1140 
A (N = 163) 1.8 3.6 4.0 3.1 24.6 32,1 16.0 24.5 
B1 (N- 447) 5.6 5.4 7.7 6.3 32.2 33.6 30.3 32.0 
B2 (N = 416) 6.6 12.0 15.3 11.3 36.5 43.0 38.7 39,4 
C (N - 114) 7.3 8.8 17.9 11.4 26.8 20.4 43,6 33.3 
~value NS NS 0.03 0.00 NS N$ 0.01 0,00 
Conclusion: The overall early and late clinical outcome is significantly 
impaired when lesion severity incmasas. This dstdmental trend in clinical 
outcome related to lesion sevedty is however prevented by the use of hirudin. 
~ Plssma Changes in Flbrinolytic end Coagulation 
Activity After PTCA 
Madhu K. Natarajan, Jerome Teitsl, Herbert I-au, Robert Chisholm, 
Bradley Strauss. St. Michasrs Hospital. Toronto, Canada 
Although ypoflbdnolysis and hypercoagulability may be contributing factors 
to restenosis no single study has comprehensively analysed these changes. 
In a pilot study, plasma fibdnolytio and coagulation activity were sedally 
followed for 3 months in 20 patients with stable angina treated with single 
vessel coronary angloplasty. As shown below, we found an eady transient 
fall in PA:-I, highly significant by one-way ANOVA. 
Notably, PAl-1 values pro-PTCA and at all times beyond 6 hr post-PTCA 
were above the normal limit of 30 IU/ml. Urokinase(uPA) levels showed a 
sustafned, significant increase beginning on day 3, An eady, non-significant 
increase in IPA and shortening of the euglobulifi lysls lime were also seen 
(not shown). Factor VII activity fell from 120 4- 10% pre PTCA to 91 4.11% 
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pest (p < 0,005) and returned to baseline levels by 24 hours. RYe of the 
20 patients required ropeat PTCA for restenosis. This subgroup had higher 
initial PAI-I levels and no dse in uPA activity on sedat measurement. 
Conclusions: Patients with stable angina have elevated PAl-1 levels which 
transiently decrease post PTCA. Elevated PAl-1 activity unopposed by an 
insmase in uPA activity may predispose to mstanosts. Based on these results 
we have initiated a larger study with mandatory repeat angtography at 6 
months. 
~ L a t e  Regression of the Dilated Lesion Alter 
Coronary Angloplasty: A 5 Year Quantitative 
Angiogrephlc Study 
John A. Ormiston, Fiona M. Stewart, Antony H.G. Roche, Bruce Webber, 
Mark W.I. Webster. Green Lane Hospital, Auckland, New Zealand 
Although clinical restenosis is uncommon beyond 6 months following coro- 
nary angioplasty (PTCA), them is little quantitative angiographio information 
on long-term changes at the PTCA site. 
Of 127 consecutive patients (pts) with successful PTCA, follow-up cinean- 
giography was obtained 'early' at 2-13 months (moan 7) in 125 pts and 
'late' at 1.5-7.8 years (mean 4.5) in 82 pts (113 lesions).-'Late' angiography 
was performed in 85%0 of those eligible; pta were excluded for repeat PTCA 
(22), mvasculadzation surgery (4) or death (3). Quantitative angiographic 
measurements (CMS-Medls) are mean 4- SD. 
PTCA Follow-Up 
Before Immediate 'Early' 'Law 
MLO (mm) 0.83 4- 0.42 1.90:1:0.48 1 .P,6 ± 0.54 2.12 :E 0.59 
Oiameler 70.3 <- 14.9 34.0 4-12.1 36.2 4-14.2 29.0 ± 11.7 
Stenosis (%) p < 0.001 p = ns p < 0.001 
Between 'eedy' and 'late' follow-up, the minimum lumen diameter (MLD) 
of 45 lesions improved by morn than 2 SD of repeat measuremanta, nd 9 
detsdorated. No patient with a lesion of < 60% diameter stennsis at 'early' 
anglography had a lesion of > 50% stenosis at 'late' aegiagraphy. 
Regression of lesion eavedty between 6 months and 5 years after PTCA is 
a frequent occurrence. This study sheds light on the matanotio process and 
may influence management of lesions of moderate severity 6 months after 
PTCA, 
~ Acute Gain and Late Loss Relationship After 
Coronary Angioplssty Correlates With Geometric 
Remodeling but Not With Changes In Plaque 
Volume 
Takeshi Kimure, Satushl Kaburegi, Himyoshl Yokoi, Yoshihlsa Nakagawa, 
Masaldyo Nobuyoshl, Gall S. Mintz, Jeifery J. Popmo, Martin B. Leon. 
KiPakyushu, Kokura Memorial Hospital, Japan, Washington Hospital Center, 
Washington DC 
Well-known relationship between acute gain lAG) and late loss (LL) after 
coronary angloplasty has been a priori explained by inflma] hyperplasla In 
mspense to injury. AG and LL relationship was analyzed in a cohort of patients 
enrolled in a prospective study by eadai intravascutsr ultrasound (IVUS) 
(motodznd pullback @ 0.5 turn/sac) and quantitative comnanj angiegraphy 
(QCA) (CAAS II) after balloon angioplasty (BA) and directional coronary 
atheroctomy (DCA). Serial studies (pre, past, and 6 months (mos)) with 
adequate IVUS images were completed in 65 lesions (DCA 28, BA 37) (93%) 
out of 70 eligible lesions. The anatomic slice selected for eadai analysis had 
an axlallocation within the target lesion atthe smallest pre-intervention lumen 
cross.sectional rea. 
